Benign Skin and Subcutaneous Lesions Commissioning Policy

This is a summary of the Northern, Eastern and Western CCG commissioning policy for assessment and removal of Benign Skin and Subcutaneous Lesions

Assessment and Removal of Benign Skin and Subcutaneous Lesions Commissioning Policy

Accompanying clinical policy patient support information for the Benign Skin and Subcutaneous Lesions Policy

Referral

Referral Criteria

Removal of a benign skin or subcutaneous lesion for cosmetic purposes using surgery, cryotherapy or laser treatment is not routinely commissioned.

Referral will only be funded if:

Recurrent (2 or more documented episodes) or persistent infection of a lesion which has required treatment with systemic antibiotics

Or

Children with port wine stains (capillary malformations) should be referred early to a paediatric dermatologist for confirmation of the diagnosis and prognosis. Cosmetic treatment of port wine stains is not routinely commissioned and will not normally be funded by the NHS through a clinician may request exceptional funding.

Clinicians referring on this basis should make the patient and parent/carer explicitly aware that treatment of the lesion may not occur.

Or

Children with large, complex or facial capillary haemangiomas at risk of causing significant disfigurement or functional impairment or a haemangioma which is ulcerating should be referred urgently to a paediatric dermatologist for confirmation of the diagnosis and consideration of early propranolol therapy.

Or

Vascular anomalies (including capillary malformations, capillary haemangiomas, venous and arterial malformations) in children can cause diagnostic uncertainty in primary care. Referral to a paediatric dermatologist is recommended if there is diagnostic uncertainty, particularly for head and neck anomalies, in children.

Clinicians referring on this basis should make the patient and parent/carer explicitly aware that treatment of the lesion may not occur.

Or

Pyogenic granuloma should only be referred if the lesion is persistent and has not responded to treatment in primary care (curettage and cautery and sending for histological confirmation of diagnosis) and if recurrently bleeding.

Where the original referral was for suspected malignancy, once it is established that a skin lesion is not malignant its removal will not normally be funded by the NHS though a clinician may request exceptional funding.

Clinicians referring on this basis should make the patient explicitly aware that removal of the lesion may not occur.

Referral Instructions

Where the circumstances of treatment for an individual patient do not meet the criteria described above exceptional funding can be sought. Individual cases will be reviewed by the appropriate panel of the CCG upon receipt of a completed application from the patient's GP, consultant or clinician. Applications cannot be considered from patients personally.

Applications for consideration for funding approval should be sent to:

Email: d-ccg.ifr-newsdt@nhs.net

Alternatively, please send to: The Panel administrator at Bridge House, Collett Way, Newton Abbot, TQ12 4PH

Supporting Information

Patient Information

Accompanying clinical policy patient support information for the Benign Skin and Subcutaneous Lesions Policy

Individual Funding Request (IFR) Patient information leaflet

Pathway Group

Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group

Date of publication: 11 January 2016

 

Home > Referral > Policies > Benign Skin and Subcutaneous Lesions Commissioning Policy

 

  • First line
  • Second line
  • Specialist
  • Hospital